https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-05-16 14:13:152016-11-28 14:13:41SuperGen Reports Results of Phase III Rescue Study With Orathecin™ (Rubitecan Capsules) Versus 5-FU in Pancreatic Cancer Patients
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-03-08 14:14:212016-11-28 14:14:44SuperGen Appoints Allan R. Goldberg, Ph.D. to Board of Directors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-03-03 14:14:522016-11-28 14:15:13SuperGen Initiates Phase II Combination Trial of Orathecin™ and Gemcitabine in Chemotherapy Naive Pancreatic Cancer Patients
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-02-09 14:16:442016-11-28 14:17:05Dr. Joseph Rubinfeld Resigns From Supergen’s Board Of Directors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2005-01-03 14:17:142016-11-28 14:17:39Dacogen™ NDA Accepted for Filing by FDA